Genetics supersedes epigenetics in colon cancer phenotype

Cancer Cell

Volumn 4, Issue 2, 2003, Pages 121-131

  Yamashita, Kentaro ^a   Dai, Tomoko ^a   Dai, Yuichi ^a   Yamamoto, Fumiichiro ^a   Perucho, Manuel ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

AGE DISTRIBUTION; ARTICLE; CANCER GENETICS; CELL MUTANT; COLON CARCINOMA; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EVALUATION; GENE LOCATION; GENE SILENCING; GENETIC EPISTASIS; HUMAN; HUMAN TISSUE; MISMATCH REPAIR; MUTATOR GENE; NORMAL DISTRIBUTION; PRIORITY JOURNAL; RANDOMIZATION; SUPPRESSOR GENE; TISSUE SPECIFICITY;

EID: 0041382819     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00190-9     Document Type: Article

References (69)

1. Ahuja N., Mohan A.L., Li Q., Stolker J.M., Herman J.G., Hamilton S.R., Baylin S.B., Issa J.P.J. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res. 57:1997;3370-3374.
2. Baylin S., Bestor T.H. Altered methylation patterns in cancer cell genomes. cause or consequence? Cancer Cell. 1:2002;299-305.
3. Bird A. Molecular biology. Methylation talk between histones and DNA. Science. 294:2001;2113-2115.
4. Boland C.R., Thibodeau S.N., Hamilton S.R., Sidransky D., Eshleman J.R., Burt R.W., Meltzer S.J., Rodriguez-Bigasu M.A., Fodde R., Ranzani G.N., Srivastava S. A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition. Development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res. 58:1998;5248-5257.
5. Breivik J., Gaudernack G. Carcinogenesis and natural selection. a new perspective to the genetics and epigenetics of colorectal cancer Adv. Cancer Res. 76:1999;187-212.
6. Breivik J., Lothe R.A., Meling G.I., Rognum T.O., Borresen-Dale A.L., Gaudernack G. Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int. J. Cancer. 74:1997;664-669.
7. Cahill, D.P., Kinzler, K.W., Vogelstein, B., and Lengauer, C. (1999). Genetic instability and Darwinian selection in tumors. Trends in Cell Biol. M57-M60.
8. Chan A.O.O., Issa J.P.J., Morris J.S., Hamilton S.R., Rashid A. Concordant CpG island methylation in hyperplastic polyposis. Am. J. Pathol. 160:2002;529-536.
9. Eads C.A., Lord R.V., Wichramasinghe K., Long T.I., Kurumboor S.K., Bernstein L., Peters J.H., DeMeester S.R., DeMeester T.R., Skinner K.A., Laird P.W. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res. 61:2001;3410-3418.
10. Eden A., Gaudet F., Waghmare A., Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science. 300:2003;455.
11. Elsaleh H., Joseph D., Grieu F., Zeps N., Spry N., Iacopetta B. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet. 355:2000;1745-1750.
12. Esteller M., Hamilton S.R., Burger P.C., Baylin S.B., Herman J.G. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res. 59:1999;793-797.
13. Esteller M., Corn P.G., Baylin S.B., Herman J.G. A gene hypermethylation profile of human cancer. Cancer Res. 61:2001;3225-3229.
14. Feinberg A.P., Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature. 301:1983;89-92.
15. Gardiner-Garden M., Frommer M. CpG islands in vertebrate genomes. J. Mol. Biol. 196:1987;261-282.
16. Graff J.R., Herman J.G., Myohanen S., Baylin S.B., Vertino P.M. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J. Biol. Chem. 272:1997;22322-22329.
17. Hawkins N., Norrie M., Cheong K., Mokany E., Ku S.L., Meagher A., O'Connor T., Ward R. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology. 122:2002;1376-1387.
18. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B. Methylation-specific PCR. a novel PCR assay for methylation status of CpG islands Proc. Natl. Acad. Sci. USA. 93:1996;9821-9826.
19. Iacopetta B. Aberrant DNA methylation. have we entered the era of more than one type of colorectal cancer? Am. J. Pathol. 162:2003;1043-1045.
20. Ionov Y., Peinado M.A., Malkhosyan S., Shibata D., Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature. 363:1993;558-561.
21. Issa J.P., Ottaviano Y.L., Celano P., Hamilton S.R., Davidson N.E., Baylin S.B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet. 7:1994;536-540.
22. Jenuwein T., Allis C.D. Translating the histone code. Science. 293:2001;1074-1080.
23. Jones P.A., Laird P.W. Cancer epigenetics comes of age. Nat. Genet. 21:1999;163-167.
24. Jones P.A., Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3:2002;415-428.
25. Kane M.F., Loda M., Gaida G.M., Lipman J., Mishra L., Goldman H., Jessup J.M., Kolodner R. Methylation of the hHMLH1 promoter correlates with lack of expression of hHMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57:1997;808-811.
26. Kim H., Jen J., Vogelstein B., Hamilton S.R. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite instability. Am. J. Pathol. 145:1994;148-156.
27. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 87:1996;159-170.
28. Kolodner R.D., Marsischky G.T. Eukaryotic DNA mismatch repair. Curr. Opin. Genet. Dev. 9:1999;89-96.
29. Kuismanen S.A., Holmberg M.T., Salovaara R., Schweizer P., Aaltonen L.A., de la Chapelle A., Nystrom-Lahti M., Peltomaki P. Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers. Proc. Natl. Acad. Sci. USA. 96:1999;12661-12666.
30. Kuismanen S.A., Holmberg M.T., Salovaara R., de la Chapelle A., Peltomaki P. Genetic and epigenetic modification of HMLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am. J. Pathol. 156:2000;1773-1779.
31. Kutsenko A.S., Gizatullin R.Z., Al-Amin A.N., Wang F., Kvasha S.M., Podowski R.M., Matushkin Y.G., Gyanchandani A., Muravenko O.V., Levitsky V.G.et al. NotI flanking sequences. a tool for gene discovery and verification of the human genome Nucleic Acids Res. 30:2002;3163-3170.
32. Laird P.W. The power and the promise of DNA methylation markers. Nat. Rev. Cancer. 3:2003;253-266.
33. Laird P.W., Jackson-Grusby L., Fazeli A., Dickinson S.L., Jung W.E., Li E., Weinberg R.A., Jaenisch R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell. 81:1995;197-205.
34. Lipkin M., Sherlock P., Bell B. Cell proliferation kinetics in the gastrointestinal tract of man. Gastroenterology. 45:1963;721-729.
35. Lindblom A. Different mechanisms in the tumorigenesis of proximal and distal colon cancers. Curr. Opin. Oncol. 13:2001;63-69.
36. Loeb L.A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51:1991;3075-3079.
37. Malkhosyan S.R., Yamamoto H., Piao Z., Perucho M. Late onset and high incidence of colon cancer of the mutator phenotype with hypermethylated hHMLH1 gene in women. Gastroenterology. 119:2000;598.
38. Markowitz S.D., Wang J., Myeroff L., Parsons R., Sun L., Lutterbaugh J., Fan R.S., Zborowska E., Kinzler K.W., Vogelstein B.et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science. 268:1995;1336-1338.
39. Olschwang S., Hamelin R., Laurent-Puig P., Thuille B., De Rycke Y., Li Y.J., Muzeau F., Girodet J., Salmon R.J., Thomas G. Alternative genetic pathways in colorectal carcinogenesis. Proc. Natl. Acad. Sci. USA. 94:1997;12122-12127.
40. Peltomaki P., de la Chapelle A., Kuismanen S.A., Holmberg M.T., Salovaara R. Reply to Perucho M., Genetic and epigenetic modification of HMLH1. Am. J. Pathol. 157:2000;1052-1053.
41. Perucho M. Cancer of the microsatellite mutator phenotype. Biol. Chem. 377:1996;675-684.
42. Perucho M. Correspondence re. C.R. Boland et al Cancer Res. 59:1999;249-253.
43. Perucho M., Peinado M.A., Ionov Y., Casares S., Malkhosyan S., Stanbridge E. Defects in replication fidelity of simple repeated sequences reveal a new mutator mechanism for oncogenesis. Cold Spring Harb. Symp. Quant. Biol. 59:1994;339-348.
44. Potten S.C., Kellett M., Roberts S., Rew D., Wilson G. The in vivo measurement of proliferation in normal human colorectal mucosa using bromodeoxyuridine. Gut. 33:1992;71-78.
45. Rampino N., Yamamoto H., Ionov Y., Li Y., Sawai H., Reed J.C., Perucho M. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science. 275:1997;967-969.
46. Rashid A., Shen L., Morris J.S., Issa J.P.J., Hamilton S.R. CpG island methylation in colorectal adenomas. Am. J. Pathol. 159:2001;1129-1135.
47. Shen L., Ahuja N., Shen Y., Habib N.A., Toyota M., Rashid A., Issa J.P.J. DNA methylation and environmental exposure in human hepatocellular carcinoma. J. Natl. Cancer Inst. 94:2002;755-761.
48. Shen L., Kondo Y., Hamilton S.R., Rashid A., Issa J.P.J. p14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53. Gastroenterology. 124:2003;626-633.
49. Shibata D., Peinado M.A., Ionov Y., Malkhosyan S., Perucho M. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nat. Genet. 6:1994;273-281.
50. Strathdee G., Appleton K., Illand M., Millian D.W.M., Sargent J., Paul J., Brown R. Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes. Am. J. Pathol. 158:2001;1121-1127.
51. Suzuki K., Dai T., Suzuki I., Dai Y., Yamashita K., Perucho M. Low mutation incidence in polymorphic noncoding short mononucleotide repeats in gastrointestinal cancer of the microsatellite mutator phenotype pathway. Cancer Res. 62:2002;1961-1965.
52. Thibodeau S.N., Bren G., Schaid D.J. Microsatellite instability in cancer of the proximal colon. Science. 260:1993;816-819.
53. Toyota M., Issa J.P. The role of DNA hypermethylation in human neoplasia. Electrophoresis. 21:2000;329-333.
54. Toyota M., Ahuja N., Ohe-Toyota M., Herman J.G., Baylin S.B., Issa J.P.J. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA. 96:1999;8681-8686. a.
55. Toyota M., Ahuja N., Suzuki H., Itoh F., Ohe-Toyota M., Imai K., Baylin S.B., Issa J.P.J. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 59:1999;5438-5442. b.
56. Toyota M., Ohe-Toyota M., Ahuja N., Issa J.P.J. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc. Natl. Acad. Sci. USA. 97:2000;710-715.
57. Tsao J.L., Yatabe Y., Salovaara R., Jarvinen H.J., Mecklin J.P., Aaltonen L.A., Tavare S., Shibata D. Genetic reconstruction of individual colorectal tumor histories. Proc. Natl. Acad. Sci. USA. 97:2000;1236-1241.
58. Tsuchiya T., Tamura G., Sato K., Endoh Y., Sakata K., Jin Z., Motoyama T., Usuba O., Kimura W., Nishizuka S.et al. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene. 19:2000;3642-3646.
59. Turner B.M. Cellular memory and the histone code. Cell. 111:2002;285-291.
60. Ueki T., Toyota M., Sohn T., Yeo C.J., Issa J.P.J., Hruban R.H., Goggins M. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res. 60:2000;1835-1839.
61. van Rijnsoever M., Grieu F., Elsaleh H., Joseph D., Iacopetta B. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut. 51:2002;797-802.
62. INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 8:1999;501-506.
63. Woerner S.M., Benner A., Sutter C., Schiller M., Yuan Y.P., Keller G., Bork P., Doeberitz M.K., Gebert J.F. Pathogenesis of DNA repair-deficient cancers. a statistical meta-analysis of putative Real Common Target genes Oncogene. 22:2003;2226-2235.
64. Yamamoto H., Sawai H., Perucho M. Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res. 57:1997;4420-4426.
65. Yamamoto H., Perez-Piteira J., Yoshida T., Terada M., Itoh F., Imai K., Perucho M. Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features. Gastroenterology. 116:1999;1348-1357.
66. Yamamoto F., Yamamoto M., Soto J.L., Kojima E., Wang E.N., Perucho M., Sekiya T., Yamanaka H. NotI-MseI methylation-sensitive amplified fragment length polymorphism for DNA methylation analysis of human cancers. Electrophoresis. 22:2001;1946-1956. a.
67. Yamamoto H., Itoh F., Nakamura H., Fukushima H., Sasaki S., Perucho M., Imai K. Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability. Cancer Res. 61:2001;3139-3144. b.
68. Yamamoto H., Imai K., Perucho M. Gastrointestinal cancer of the microsatellite mutator phenotype pathway. J. Gastroenterol. 37:2002;153-163.
69. Yan P.S., Efferth T., Chen H., Lin J., Rodel F., Fuzesi L., Huang T. Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation. Methods. 27:2002;162-169.